CA Patent

CA3180560A1 — Bioavailable sugar-based diclofenac formulations

Assigned to APR Applied Pharma Research SA · Expires 2021-12-16 · 4y expired

What this patent protects

Ready to use liquid formulations of diclofenac potassium are disclosed which are particularly well suited for packaging in stick-packs.

USPTO Abstract

Ready to use liquid formulations of diclofenac potassium are disclosed which are particularly well suited for packaging in stick-packs.

Drugs covered by this patent

diclofenac-potassium (DICLOFENAC POTASSIUM)

Patent Metadata

Patent number: CA3180560A1
Jurisdiction: CA
Classification: —
Expires: 2021-12-16
Drug substance claim: No
Drug product claim: No
Assignee: APR Applied Pharma Research SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.